The Future of Pharma Across All Sectors in the Artificial Intelligence Era. Este artículo no está disponible.The Future of Pharma Across All Sectors in the Artificial Intelligence Era

The Future of Pharma Across All Sectors in the Artificial Intelligence Era offers a thorough examination of the pharmaceutical industry's current landscape, highlighting the myriad challenges, opportunities, and trends that are poised to shape its future. Edited by experts, this book delves into transformative technological advancements, including artificial intelligence, machine learning, big data analytics, and blockchain. These technologies are redefining pharmaceutical research, development, and commercialization, making precision medicine and personalized therapies a reality, while integrating genomic medicine into the pharmaceutical value chain. Additionally, the book addresses educational implications for academic curricula, emphasizing the need for digital transformation in healthcare delivery models. It scrutinizes regulatory trends and compliance, offering insights into navigating complex landscapes to ensure product quality and safety. The book emphasizes the pharmaceutical industry's role in tackling infectious diseases and health disparities, promoting health equity through innovative drug development and access initiatives. Future trends and predictions are speculated upon, considering demographic shifts and evolving healthcare needs, while market dynamics and commercial strategies are analyzed to equip pharmaceutical companies with practical recommendations for navigating competitive landscapes.

Miltiadis D. Lytras is a Professor of Artificial Intelligence, Digital Transformation, and Knowledge Management at Effat University (Saudi Arabia) and The American College of Greece. He is an internationally recognized researcher with extensive experience in AI, data science, smart systems, and digital innovation across healthcare, education, government, and business. He has served as Principal Investigator and Senior Researcher in numerous international and national research projects and has published more than 100 peer-reviewed articles and over 40 books with leading international publishers. His work focuses on responsible and human-centered AI, advanced decision-making systems, and the strategic impact of emerging technologies on organizations and society.

Ahmed is an experienced professional with almost 2 decades of expertise in pharmaceutical, academia, and healthcare industries. He has strong leadership skills, excellent communication abilities, and an entrepreneurial spirit. He specializes in clinical trials and has a proven track record of designing and running international, multicentre clinical trial projects. He is a thought leader in R&D ecosystem transformation and the use of technology to advance health. He also has a strong network of investigators and key opinion leaders, both locally and globally, and is actively involved in various initiatives to unlock the clinical trials ecosystem. Ahmed is passionate about enabling others to conduct more clinical trials with the ultimate aim of improving the health of millions of people around the world.

Patricia de Pablos is a Professor of Business Administration at the University of Oviedo in Spain. Her field of research focuses on knowledge management, healthcare sector, innovation, information technologies and technological disruption. She has contributed to numerous academic publications. She has wide editorial experience in journals, books and book series. She serves as Editor in Chief of International Journal of Asian Business and Information and Journal of Science and Technology Policy Management.

Paraskevi Papadopoulou is Professor of Biology in the Biomedical Sciences and Environmental Studies Programs, Department of Natural Sciences, School of Science and Technology at Deree-The American College of Greece, Athens, Greece. Her research activity covers a wide range of subject areas with a main focus in the fields of structural biology/molecular biophysics and bioinformatics and on structural and self-assembly studies of fibrous proteins. Her current research engagement expands on environmental health issues, big data analytics in bioinformatics, medicine, health and healthcare, the evolution of consciousness plus on Mediterranean biodiversity and green roofs, and innovative teaching and learning methods in STEM disciplines. https://acg150.acg.edu/persons/paraskevi-papadopoulou-phd/

Dr Sofia Konstantinopoulou, MD, FAAP, is a triple US board-certified pediatric pulmonologist and sleep medicine physician. She completed her training and gained extensive experience at the Children’s Hospital of Philadelphia, where she also held an academic position as Assistant Professor of Pediatrics at the Perelman School of Medicine at the University of Pennsylvania.

Currently, Dr Konstantinopoulou serves as an attending physician specializing in pediatric pulmonology and sleep medicine at Sheikh Khalifa Medical City (SEHA), the premier referral center for pediatrics in the country. In this role, she manages some of the most challenging cases in pediatric respiratory and sleep medicine, collaborating closely with multidisciplinary teams to deliver compassionate, family-centered care. She also holds the position of clinical lead for the Aerodigestive Program at her institution.

With a primary focus on patients with sleep-disordered breathing requiring home mechanical ventilation, Dr Konstantinopoulou is dedicated to providing high-quality care and improving outcomes for these individuals. She plays a pivotal role in medical education as core faculty for her institution's ACGME-accredited pediatric residency program and the World Sleep Academy (WSA).

Additionally, Dr Konstantinopoulou is actively involved in professional organizations such as CHEST, the American Academy of Sleep Medicine (AASM), and the American Thoracic Society (ATS), where she contributes her expertise as a member of the International Health Committee.

Passionate about collaboration and advancing clinical research, health advocacy, and medical education, Dr Konstantinopoulou welcomes opportunities to work with partners worldwide on impactful projects in her field.